DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

Information source: Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Anxiety

Intervention: Pregabalin (Drug); Venlafaxine XR (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Summary

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

Clinical Details

Official title: An 8-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study Of Pregabalin (300-600 Mg/Day) And Venlafaxine XR (75-225 Mg/Day) For The Acute Treatment Of DSM-IV Generalized Anxiety Disorder In Outpatients

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Primary outcome: Evaluation of the efficacy of pregabalin and Venlafaxine XR in the treatment of generalized anxiety disorder.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Male and female outpatients with diagnosis of generalized anxiety disorder.

Exclusion Criteria:

- Any serious or uncontrolled medical condition.

- Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.

Locations and Contacts

Pfizer Investigational Site, De Pinte, Belgium

Pfizer Investigational Site, Gent, Belgium

Pfizer Investigational Site, Ghent, Belgium

Pfizer Investigational Site, Waregem, Belgium

Pfizer Investigational Site, Angouleme, France

Pfizer Investigational Site, Arcachon, France

Pfizer Investigational Site, Bully Les Mines, France

Pfizer Investigational Site, Cherbourg, France

Pfizer Investigational Site, Elancourt, France

Pfizer Investigational Site, Orvault, France

Pfizer Investigational Site, Rennes, France

Pfizer Investigational Site, Saint-andre-de-cubzac, France

Pfizer Investigational Site, Savigny Sur Orge, France

Pfizer Investigational Site, Strasbourg, France

Pfizer Investigational Site, Versailles, France

Pfizer Investigational Site, Catania, Italy

Pfizer Investigational Site, Sassari, Italy

Pfizer Investigational Site, Hoogvliet, Netherlands

Pfizer Investigational Site, Huizen, Netherlands

Pfizer Investigational Site, Losser, Netherlands

Pfizer Investigational Site, Musselkanaal, Netherlands

Pfizer Investigational Site, Oude Pekela, Netherlands

Pfizer Investigational Site, Barcelona, Spain

Pfizer Investigational Site, Madrid, Spain

Pfizer Investigational Site, Salamanca, Spain

Pfizer Investigational Site, Zamora, Spain

Pfizer Investigational Site, Göteborg, Sweden

Pfizer Investigational Site, Linkoping, Sweden

Pfizer Investigational Site, Lund, Sweden

Pfizer Investigational Site, Malmö, Sweden

Pfizer Investigational Site, Stockholm, Sweden

Pfizer Investigational Site, Sundsvall, Sweden

Pfizer Investigational Site, Trollhattan, Sweden

Pfizer Investigational Site, Langreo, Asturias, Spain

Pfizer Investigational Site, VIC, Barcelona, Spain

Pfizer Investigational Site, Vicenza, Bassano Del Grappa, Italy

Pfizer Investigational Site, Kelowna, British Columbia, Canada

Pfizer Investigational Site, Bray, County Wicklow, Ireland

Pfizer Investigational Site, Wildervank, GR, Netherlands

Pfizer Investigational Site, Alcala de Henares, Madrid, Spain

Pfizer Investigational Site, Hamilton, Ontario, Canada

Pfizer Investigational Site, Ottawa, Ontario, Canada

Pfizer Investigational Site, Citta' Di Castello, Perugia, Italy

Pfizer Investigational Site, Gatineau, Quebec, Canada

Pfizer Investigational Site, Saint-Jean-Sur-Richelieu, Quebec, Canada

Pfizer Investigational Site, Gandia, Valencia, Spain

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: March 2005
Last updated: March 19, 2008

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017